BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36873946)

  • 1. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
    Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
    Front Genet; 2023; 14():1109491. PubMed ID: 36873946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
    Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
    Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
    Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
    Conley AP; Wang WL; Livingston JA; Ravi V; Tsai JW; Ali A; Ingram DR; Lowery CD; Roland CL; Somaiah N; Hwu P; Yee C; Subbiah V; Futreal A; Lazar AJ; Patel S; Roszik J
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31096717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
    Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
    Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival.
    Li GZ; Okada T; Kim YM; Agaram NP; Sanchez-Vega F; Shen Y; Tsubokawa N; Rios J; Martin AS; Dickson MA; Qin LX; Socci ND; Singer S
    Cancer Res; 2020 Jun; 80(12):2461-2471. PubMed ID: 32161142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Lee AY; Agaram NP; Qin LX; Kuk D; Curtin C; Brennan MF; Singer S
    Ann Surg Oncol; 2016 Mar; 23(3):818-25. PubMed ID: 26759307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
    Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
    J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
    Song B; Lee K; Lee C; Moon KC
    Pathol Int; 2018 Sep; 68(9):509-516. PubMed ID: 30094896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall.
    Danieli M; Barretta F; Radaelli S; Fiore M; Sangalli C; Barisella M; Palassini E; Miceli R; Frezza AM; Callegaro D; Collini P; Casali PG; Stacchiotti S; Gronchi A
    Cancer; 2023 Nov; 129(21):3417-3429. PubMed ID: 37452607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
    Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
    Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma].
    Guo H; Xiong Y; Nong L; Zhang S; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):374-9. PubMed ID: 18677383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undifferentiated pleomorphic sarcoma of the floor of mouth: A rare case.
    Sharma A; Vyas P; Agarwal D
    J Oral Maxillofac Pathol; 2023 Feb; 27(Suppl 1):S33-S37. PubMed ID: 37082283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications.
    Pestana RC; Roszik J; Groisberg R; Sen S; Van Tine BA; Conley AP; Subbiah V
    Curr Probl Cancer; 2021 Oct; 45(5):100794. PubMed ID: 34656365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
    Vanni S; De Vita A; Gurrieri L; Fausti V; Miserocchi G; Spadazzi C; Liverani C; Cocchi C; Calabrese C; Bongiovanni A; Riva N; Mercatali L; Pieri F; Casadei R; Lucarelli E; Ibrahim T
    Ther Adv Med Oncol; 2022; 14():17588359221093973. PubMed ID: 35782752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant fibrous histiocytoma, now referred to as Undifferentiated Pleomorphic Sarcoma: A Case Report of an unexpected histology of a subcutaneous lesion.
    Seomangal K; Mahmoud N; McGrath JP
    Int J Surg Case Rep; 2019; 60():299-302. PubMed ID: 31277040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Ultrasound for Evaluation of a Large Undifferentiated Pleomorphic Sarcoma in the Lower Extremity of an Elderly Male.
    Gencarelli P; Hali A; Aurup J
    Cureus; 2022 Oct; 14(10):e30153. PubMed ID: 36397898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.